NCT05935397

Brief Summary

The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry. The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
11.5 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 7, 2023

Status Verified

June 1, 2023

Enrollment Period

14 years

First QC Date

June 29, 2023

Last Update Submit

June 29, 2023

Conditions

Coronary Artery StenosisCoronary Artery DiseaseBlood Pressure

Outcome Measures

Primary Outcomes (1)

  • MACCE (major adverse cardiac and cerebrovascular event)

    the composite of all-cause death, myocardial infarction, stroke, or any revascularization

    10-year

Secondary Outcomes (4)

  • All-cause death

    10-year

  • Myocardial infarction,

    10-year

  • Stroke

    10-year

  • Any revascularization

    10-year

Study Arms (1)

patients with CAD undergoing PCI

patients with CAD undergoing PCI with second generation DES

Device: percutaneous coronary intervention

Interventions

percutaneous coronary interventionDEVICE

patients with CAD undergoing PCI with second generation DES

patients with CAD undergoing PCI

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with CAD

You may qualify if:

  • Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.

You may not qualify if:

  • second or subsequent hospitalization records of patients with multiple admissions
  • patients who died during index hospitalization
  • patients who treated with first-generation drug eluting stent
  • patients with an outpatient follow-up record of less than 6 months
  • patients with insufficient medical records.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hanyang University Guri Hospital

Guri-si, 11923, South Korea

RECRUITING

Hanyang University Seoul Hospital

Seoul, 04763, South Korea

RECRUITING

Young-Hyo Lim

Seoul, 04763, South Korea

RECRUITING

Related Publications (2)

  • Kim BS, Lim YH, Shin J, Shin JH. Association of systolic blood pressure target and variability with long-term clinical outcomes in patients undergoing percutaneous coronary intervention. Clin Hypertens. 2025 Apr 1;31:e13. doi: 10.5646/ch.2025.31.e13. eCollection 2025.

    PMID: 40201318DERIVED

  • Kim BS, Shin JH, Kim W, Kook H, Lee Y, Park JK, Shin J, Lim YH. Association of office blood pressure with ischemic and bleeding events in patients undergoing percutaneous coronary intervention. Sci Rep. 2024 Sep 2;14(1):20310. doi: 10.1038/s41598-024-71060-8.

    PMID: 39218965DERIVED

MeSH Terms

Conditions

Coronary StenosisCoronary Artery Disease

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

June 29, 2023

First Posted

July 7, 2023

Study Start

January 1, 2012

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

July 7, 2023

Record last verified: 2023-06

Locations

KR(3)